Cargando…
Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy
Plasmacytoid dendritic cells (pDCs) are multifaceted immune cells with a wide range of innate and adaptive immunological functions. They constitute the first line of defence against multiple viral infections and have also been reported to actively participate in antitumor immune responses. The clini...
Autores principales: | Hernández, Sabina Sánchez, Jakobsen, Martin Roelsgaard, Bak, Rasmus O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570010/ https://www.ncbi.nlm.nih.gov/pubmed/36232698 http://dx.doi.org/10.3390/ijms231911397 |
Ejemplares similares
-
Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
por: Van der Sluis, Renée Marije, et al.
Publicado: (2022) -
Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022) -
Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells
por: Laustsen, Anders, et al.
Publicado: (2021) -
Plasmacytoid Dendritic Cells as Cell-Based Therapeutics: A Novel Immunotherapy to Treat Human Immunodeficiency Virus Infection?
por: van der Sluis, Renée M., et al.
Publicado: (2020) -
Plasmacytoid dendritic cells in dermatology()()
por: Dias de Oliveira, Natasha Favoretto, et al.
Publicado: (2021)